[go: up one dir, main page]

WO2000065053A3 - Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou - Google Patents

Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou Download PDF

Info

Publication number
WO2000065053A3
WO2000065053A3 PCT/US2000/010687 US0010687W WO0065053A3 WO 2000065053 A3 WO2000065053 A3 WO 2000065053A3 US 0010687 W US0010687 W US 0010687W WO 0065053 A3 WO0065053 A3 WO 0065053A3
Authority
WO
WIPO (PCT)
Prior art keywords
head
neck
compositions
diagnosis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/010687
Other languages
English (en)
Other versions
WO2000065053A2 (fr
Inventor
Tongtong Wang
Davin C Dillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Priority to EP00928254A priority Critical patent/EP1173570A2/fr
Priority to AU46515/00A priority patent/AU4651500A/en
Priority to CA002370482A priority patent/CA2370482A1/fr
Publication of WO2000065053A2 publication Critical patent/WO2000065053A2/fr
Publication of WO2000065053A3 publication Critical patent/WO2000065053A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des compositions et des procédés utilisés en thérapie et dans le diagnostic du cancer, notamment le cancer de la tête et du cou et le cancer des poumons. Ces compositions peuvent comprendre une ou plusieurs protéines tumorales de la tête et du cou, des parties immunogènes ou des polynucléotides codant ces parties. En variante, une composition thérapeutique peut comprendre une cellule présentant un antigène et qui exprime une protéine tumorale de la tête et du cou, ou un lymphocyte T spécifique des cellules exprimant cette protéine. Ces compositions peuvent être utilisées, par exemple, dans la prévention et le traitement de maladies telles que le cancer de la tête et du cou et le cancer des poumons. L'invention porte également sur des procédés diagnostiques basés sur la détection, dans un échantillon, d'une protéine tumorale de la tête et du cou, ou d'un ARNm codant cette protéine.
PCT/US2000/010687 1999-04-23 2000-04-21 Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou Ceased WO2000065053A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00928254A EP1173570A2 (fr) 1999-04-23 2000-04-21 Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou
AU46515/00A AU4651500A (en) 1999-04-23 2000-04-21 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma
CA002370482A CA2370482A1 (fr) 1999-04-23 2000-04-21 Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13090699P 1999-04-23 1999-04-23
US60/130,906 1999-04-23
US09/533,870 2000-04-20

Publications (2)

Publication Number Publication Date
WO2000065053A2 WO2000065053A2 (fr) 2000-11-02
WO2000065053A3 true WO2000065053A3 (fr) 2001-07-19

Family

ID=22446911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010687 Ceased WO2000065053A2 (fr) 1999-04-23 2000-04-21 Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou

Country Status (4)

Country Link
EP (1) EP1173570A2 (fr)
AU (1) AU4651500A (fr)
CA (1) CA2370482A1 (fr)
WO (1) WO2000065053A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219768A1 (en) * 2001-11-02 2003-11-27 Beebe Jean S. Lung cancer therapeutics and diagnostics
CN103397096A (zh) * 2013-08-05 2013-11-20 浙江天科高新技术发展有限公司 一种检测肝细胞癌的生物标记物及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US5776676A (en) * 1992-05-20 1998-07-07 The United States Of America As Represented By The Department Of Health And Human Services HME1 nucleic acids and probes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776676A (en) * 1992-05-20 1998-07-07 The United States Of America As Represented By The Department Of Health And Human Services HME1 nucleic acids and probes
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AE KISIELEWSKI ET AL.: "Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck", ONCOGENE, vol. 17, no. 1, 9 July 1998 (1998-07-09), ISSN:0950-9232, pages 83 - 91, XP000953059 *
DB VILLARET ET AL.: "Identification of genes overexpressed in head and neck squamous cel carcinoma using a combination of complementary DNA subtraction and microarray analysis", THE LARYNGOSCOPE, vol. 110, no. 3, March 2000 (2000-03-01), ISSN:0023-852X, pages 374 - 381, XP000953135 *
G CHAN ET AL.: "Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck", CANCER RESEARCH, vol. 59, no. 3, 1 March 1999 (1999-03-01), MD US, pages 991 - 994, XP002151072 *

Also Published As

Publication number Publication date
AU4651500A (en) 2000-11-10
EP1173570A2 (fr) 2002-01-23
WO2000065053A2 (fr) 2000-11-02
CA2370482A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
WO2001000828A3 (fr) Compositions et techniques de therapie et de diagnostic du cancer du poumon
WO2001025272A3 (fr) Compositions et methodes de therapie et de diagnostic du cancer de la prostate
WO2000004149A3 (fr) Compositions et methodes de therapie et de diagnostic du cancer de la prostate
WO2001040269A3 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
WO2000060077A3 (fr) Composes utilises dans la therapie et le diagnostic du cancer du poumon et methodes d'utilisation
WO2001096388A8 (fr) Compositions et procedes servant a traiter et a diagnostiquer le cancer du colon
WO2001096390A3 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer du colon
WO2000060076A3 (fr) Compositions pour le traitement et le diagnostic du cancer du sein et leurs procedes d'utilisation
WO2001034802A3 (fr) Compositions et methodes de traitement et de diagnostic du cancer de la prostate
WO2001075171A3 (fr) Methodes, compositions et necessaires correspondants servant au depistage et a la surveillance du cancer du sein
WO2001079286A3 (fr) Compositions et procedes de traitement et de diagnostic du cancer du sein
WO2000037643A3 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
WO2002083070A3 (fr) Composes pour l'ummunotherapie et le diagnostic du cancer du colon et methodes d'utilisation associees
WO2001072295A3 (fr) Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon
WO2002004514A8 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du poumon
WO2001073027A3 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer du colon
WO2000052165A3 (fr) Compositions et methodes de therapie et de diagnostic du cancer du sein
WO2001049716A3 (fr) Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation
WO2001077168A3 (fr) Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon
WO2000078960A3 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
WO2001057207A3 (fr) Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire
WO2001051513A3 (fr) Sequences associees a une tumeur ovarienne
WO2002002623A3 (fr) Compositions et methodes de diagnostic et de traitement du cancer des poumons
WO2001070976A3 (fr) Compositions et procedes de therapie et de diagnostic du cancer des ovaires et de l'endometre
WO2001073031A3 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer de l'ovaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2370482

Country of ref document: CA

Ref country code: JP

Ref document number: 2000 614389

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: CA

Ref document number: 2370482

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000928254

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000928254

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000928254

Country of ref document: EP